Advertisement

Nephroprotective Potential of Alstonia scholaris in Cisplatin Induced Nephrotoxicity in Experimental Animals

  • Pawan K. Verma
  • Rajinder Raina
  • Mudasir Sultana
  • Maninder Singh
  • Pawan Kumar
Research Article
  • 45 Downloads

Abstract

The present investigation was aimed to determine the alterations in antioxidant, biochemical and histopathological parameters in cisplatin (cDDP) induced nephrotoxicity and its protection by treatments with aqueous and ethanolic leaf extracts of Alstonia scholaris. Acute nephrotoxicity was induced by single intra-peritoneal administration of cDDP (12 mg kg−1) in wistar rats. Nephrotoxic rats were treated with quercetin (50 mg kg−1), aqueous and ethanolic leaf extracts (300 mg kg−1) by oral gavage. Cisplatin treatment elevated (P < 0.05) the levels of blood urea nitrogen, creatinine, uric acid, total oxidant status (TOS), oxidative stress index, malondialdehyde (MDA) but lowered (P < 0.05) total plasma proteins, total antioxidant status, total thiols, blood glutathione (GSH) levels and antioxidant enzymes as compared to control. Administrations with ethanolic leaf extract following cDDP exposure restored (P > 0.05) creatinine, albumin, TOS, GSH and activities of antioxidant enzymes in blood and renal tissue. Leaf extracts administration also reduced (P < 0.05) erythrocyte and renal MDA levels following cDDP treatment. The restorations of various antioxidant and renal parameters were also supported by the histopathological findings of renal tissue. Administrations with ethanolic leaf extract have high potential to minimize cDDP induced renal damage as indicated by restoration of biochemical, antioxidant and histopathological alterations in nephrotoxic rats as compared to aqueous extract of A. scholaris.

Keywords

Total antioxidant status Oxidative stress index Nephrotoxicity Cisplatin Alstonia scholaris 

Notes

Acknowledgements

The authors thank to the Dean, Faculty of Veterinary Science and Animal Husbandry, R S Pura, Jammu for providing necessary facilities for conducting the research.

Compliance with Ethical Standards

Conflict of intrest

The authors declare there are no conflicts of interest.

References

  1. 1.
    Uchino S (2006) The epidemiology of acute renal failure in the world. Curr Opin Crit Care 12:538–543CrossRefPubMedGoogle Scholar
  2. 2.
    Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84CrossRefPubMedGoogle Scholar
  3. 3.
    Tilburt CJ, Kaptchuk JT (2008) Herbal medicine research and global health: an ethical analysis. Bull World Health Organ 86:594–599CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Dung NX, Ngoi PH, Rang DD (2001) Chemical composition of volatile concentrate from the flower of Vietnamese Alstonia scholaris (L) R.Br. J Essential Oil Res 13:424–428CrossRefGoogle Scholar
  5. 5.
    Jagetia GC, Baliga MS (2006) Evaluation of anticancer activity of the alkaloid fraction of Alstonia scholaris (Sapthaparna) in vitro and in vivo. Phytother Res 20:103–109CrossRefPubMedGoogle Scholar
  6. 6.
    Shang JH, Cai XH, Feng T et al (2010) Pharmacological evaluation of Alstonia scholaris: anti-inflammatory and analgesic effects. J Ethnopharmacol 129:174–181CrossRefPubMedGoogle Scholar
  7. 7.
    Shah AJ, Gowani SA, Zuberi AJ, Ghayur MN, Gilani AH (2010) Antidiarrhoeal and spasmolytic activities of the methanolic crude extract of Alstonia scholaris L. are mediated through calcium channel blockade. Phytother Res 24:28–32CrossRefPubMedGoogle Scholar
  8. 8.
    Shang JH, Cai XH, Zhao YL, Feng T, Luo XD (2010) Pharmacological evaluation of Alstonia scholaris: anti-tussive, anti-asthmatic and expectorant activities. J Ethnopharmacol 129:293–298CrossRefPubMedGoogle Scholar
  9. 9.
    Subraya CK, Harikiran Gupta D (2012) Antioxidant and anti-inflammatory activity of Alstonia scholaris R.Br. stem bark extract. Free Rad Antioxid 2:55–57CrossRefGoogle Scholar
  10. 10.
    Taguchi T, Nazneen A, Abid MR, Razzaque MS (2005) Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148:107–121CrossRefPubMedGoogle Scholar
  11. 11.
    Ludwig T, Riethmüller C, Gekle M, Schwerdt G, Oberleithner H (2004) Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. Kidney Int 66:196–202CrossRefPubMedGoogle Scholar
  12. 12.
    Christopher A, Dasis HSN, Agarwal A (2001) Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Society Nephrol 12:2683–2690Google Scholar
  13. 13.
    Schaaf GJ, Maas RF, De groene EM, Fink-gremmels J (2002) Management of oxidative stress by heme oxygenase-1 in cisplatin-induced toxicity in renal tubular cells. Free Radic Res 36:835–843CrossRefPubMedGoogle Scholar
  14. 14.
    Antunes LMG, Darin JDC, Bianchi MLP (2002) Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res 43:145–150CrossRefGoogle Scholar
  15. 15.
    Sener G, Satiroglu H, Kabasakal L et al (2000) The protective effect of melatonin on cisplatin nephrotoxicity. Fundamental Clin Pharmacol 14:553–560CrossRefGoogle Scholar
  16. 16.
    Behling EB, Sendão MC, Francescato HD, Antunes LM, Costa RS, Bianchi Mde L (2006) Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol Rep 58:526–532PubMedGoogle Scholar
  17. 17.
    Joy J, Nair CK (2008) Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract. J Cancer Res Ther 4:111–115CrossRefPubMedGoogle Scholar
  18. 18.
    Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Rad Biol Med 26:1231–1237CrossRefPubMedGoogle Scholar
  19. 19.
    Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111CrossRefPubMedGoogle Scholar
  20. 20.
    Motchnik AP, Frei B, Ames NB (1994) Measurement of antioxidants in human blood plasma, Protein thiols. In: Packer L (ed) Oxygen radicals in biological systems, methods in Enzymology. Academic Press, California, pp 234(D)–234-273Google Scholar
  21. 21.
    Shafiq-Ur-Rehman (1984) Lead-induced regional lipid peroxidation in brain. Toxicol Lett 21:333–337CrossRefPubMedGoogle Scholar
  22. 22.
    Aebi HE (1983) Catalase. In: Bergmeyer HU (ed) Methods of Enzymatic Analysis. Academic Press, New York, pp 276–286Google Scholar
  23. 23.
    Marklund S, Marklund G (1974) Involvement of superoxide anion radical in autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474CrossRefPubMedGoogle Scholar
  24. 24.
    Hafeman DG, Sunde RA Hoekstra WG (1974) Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutrition 104:580–587Google Scholar
  25. 25.
    Habig WH, Pabst MJ, Jakoby WB (1974) Gultathione-S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139PubMedGoogle Scholar
  26. 26.
    Beutler E (1975) Red cell metabolism, a manual of biochemical methods. Grune Stratton, New York, pp 67–69Google Scholar
  27. 27.
    Ali BH, Al moundhri MS (2006) Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol 44:1173–1183CrossRefPubMedGoogle Scholar
  28. 28.
    Puig JG, Mateos FA, Ramos TH, Capitan CF, Michan AA, Mantilla JM (1986) Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2). Advances Exper Med Biol 195(Pt A):317–323CrossRefGoogle Scholar
  29. 29.
    Maesaka JK, Fishbane S (1998) Regulation of renal urate excretion: a critical review. Am J Kidney Dis 32:917–933CrossRefPubMedGoogle Scholar
  30. 30.
    Maxwell SR, Jakeman P, Thomason H, Leguen C, Thorpe GH (1993) Changes in plasma antioxidant status during eccentric exercise and the effect of vitamin supplementation. Free Radic Res Comm. 19:191–202CrossRefGoogle Scholar
  31. 31.
    Ghiselli A, Serafini M, Natella F, Scaccini C (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 29:1106–1114CrossRefPubMedGoogle Scholar
  32. 32.
    Ronald PM, Raghu K, Tadagavadi Ramesh G (2010) William Brain Reeves. Mechanisms of cisplatin nephrotoxicity. Toxins. 2:2490–2518Google Scholar
  33. 33.
    Verma PK, Raina R, Sultana M, Prawez S, Singh M (2015) Polyphenolic constituents and antioxidant/antiradical activity in different extracts of Alstonia scholaris (Linn.). Afr J Biotech 14:3190–3197CrossRefGoogle Scholar
  34. 34.
    Uriu-Adams JY, Keen CL (2005) Copper, oxidative stress, and human health. Mol Aspects Med 26:268–298CrossRefPubMedGoogle Scholar
  35. 35.
    Mishima K, Baba A, Matsuo M, Itoh Y, Oishi R (2006) Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radic Biol Med 40:1564–1577CrossRefPubMedGoogle Scholar
  36. 36.
    Jones DP, Park Y, Gletsu-Miller N et al (2011) Dietary sulfur amino acid effects on fasting plasma cysteine/cystine redox potential in humans. Nutrition. 27:199–205CrossRefPubMedGoogle Scholar
  37. 37.
    Minakshi GC, Vasanth K, Tanupriya Ilango K, Mohan Kumar R, Agrawal A, Dubey GP (2015) Phytochemical evaluation and antioxidant potential of Garcinia indica fruits on H2O2 induced oxidative stress in THP-1 cell line. Int J Pharmacol 11:672–680CrossRefGoogle Scholar
  38. 38.
    Verma PK, Raina R, Sultana M, Singh M, Kumar P (2016) Total antioxidant and oxidant status of plasma and renal tissue of cisplatin-induced nephrotoxic rats: protection by floral extracts of Calendula officinalis Linn. Ren Fail 38:142–150CrossRefPubMedGoogle Scholar

Copyright information

© The National Academy of Sciences, India 2017

Authors and Affiliations

  • Pawan K. Verma
    • 1
  • Rajinder Raina
    • 1
  • Mudasir Sultana
    • 1
  • Maninder Singh
    • 2
  • Pawan Kumar
    • 3
  1. 1.Division of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Science and Animal HusbandrySher-e-Kashmir University of Agricultural Sciences and Technology of JammuR S Pura, JammuIndia
  2. 2.Division of Veterinary Public Health and Epidemiology, Faculty of Veterinary Science and Animal HusbandrySher-e-Kashmir University of Agricultural Sciences and Technology of JammuR S Pura, JammuIndia
  3. 3.Division of PathologyIndian Veterinary Research InstituteIzatnagar, BareillyIndia

Personalised recommendations